Pinned straw:
I’m sorry to say @Strawman my highlight of the expo was having an ice cream for the first time as a 2 year old. Unfortunately i don’t remember the experience but my mum reminds me of the criticism she got from a stranger for feeding a 2 y.o processed sugar@PabloEskyBruhnot sure if it was FDA approved then.
I first invested back in the day in admedus (now anteris) for about 4 years in 2012. It was the start of my investing career and I finally didn’t have the stomach for the continued capital raises and sold for quite some loss. (Fortunately i didn’t make much money back then so it was minimal, apart from the opportunity cost).
This is a huge market. My interest peaked during my time as a trainee in St Vincent’s hospital Sydney where I anaesthetised quite a few. So I bought more. Sadly I had no understanding of where a company was in its lifecycle during this time. Recently Wollongong hospital where I now work has started doing TAVI’s in the private hospital. My mate and colleague has come back from training in the UK for them where he did 8 a day. Yes you heard right… that is at least 4 times the efficiency of a standard aortic valve repair, where we would get 1 done a day paired with a smaller case. (I am not a cardiac anaesthetist now for the record and these are my training days). Note that there is different patient populations suitable for each procedure TAVI (which is a minimally invasive procedure) vs Open heart surgery. My understanding is that there is limited initial difference with stroke and immediate mortality depending on the study however there is a much greater rate of re-operation within 5 years. So if you are super old you get a TAVI if you are younger you get open heart surgery. Correct me if I’m wrong @PabloEskyBruh but this is what Anteris is trying to change with its technology, the length of time for re-operation.
Recently I asked the procurement nursing unit manager at wollongong private hospital what was the driving process of which TAVI device they used. I think they use Medtronic and one other I have forgotten sorry. But the main reason is they will use a heap of stents/pacemakers and the company will give them an amount of money to spend on whatever they want due to their loyalty. They often use this for TAVI’s. So the companies become entrenched in a hospital.
I was trying to find out the number of competitors and it is pretty large.
My question to you? Is the bull case that this will increase the number of years for re-operation and therefore become the dominant use case? If that hypothesis comes true this is a massive company. With the in human uses currently (2022) does that mean we will be waiting until at least 2027 to really understand this?
Cheers and thanks for reviving an old flame/nightmare ;)
I still have my bicentennial coin somewhere @PabloEskyBruh, and was.likewise told it would be "worth a lot one day". Haha
Then again, it was the people issuing the coin that were saying that..so, yeah.
(The highlight of expo88 for me was getting to sit in and talk to KIT from Knight rider. My 13 year old self was in heaven)